Oncology Consortium

Impactful Education Through Innovative Engagement

roy.berger@theoncologyconsortium.com | (516) 729-0303
Service Hours
06:00:00 - 18:00:00

Neuro-Oncology Consortium

Dr. Sampson is a Chief of Neurosurgery at Duke University with doctoral level training in Immunology and an MBA from a top Business School whose research interest is in brain tumor drug delivery and immunotherapy — activating a patient’s immune system to recognize and kill tumors. His research examines the ability of immune cells to specifically target tumor cells with little to no normal cell toxicity. He has already developed two vaccines targeting tumor-specific antigens that promises to extend the lifespan of patients with brain tumors in prospective, randomized, and placebo-controlled trials. He is currently the PI of several international trials for immunotherapy in brain tumors based on his own work and work from global pharmaceutical companies.

Oncology Consortium | All Rights Reserved 2012-2017
Back to Top